Additionally, tumor cells and, as recently discovered, endothelial cells of tumor microvasculature can upregulate FasL/CD95L, contributing to higher apoptotic rates of activated CD95+ Т lymphocytes [3] and exhaustion of effector immune cells [4]. The gene discussed is FAS; the disease is neoplasm.